Heterocyclic compounds for the treatment of neurological and psychological disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10023537
APP PUB NO 20160318869A1
SERIAL NO

15147021

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Lactam compounds of Formula I and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALKERMES PHARMA IRELAND LIMITED1 BURLINGTON ROAD CONNAUGHT HOUSE DUBLIN 4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blumberg, Laura Cook Lincoln, US 49 812
Remenar, Julius F Framingham, US 51 877
Zeidan, Tarek A Watertown, US 55 705

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 17, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 17, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00